Associations between childhood adversity and depression, substance abuse and HIV and HSV2 incident infections in rural South African youth.

Associations between childhood adversity and depression, substance abuse and HIV and HSV2 incident infections in rural South African youth.

Child Abuse Negl. 2010 Oct 11;

Authors: Jewkes RK, Dunkle K, Nduna M, Jama PN, Puren A

OBJECTIVES: To describe prevalence of childhood experiences of adversity in rural South African youth and their associations with health outcomes.

METHODS: We analyzed questionnaires and blood specimens collected during a baseline survey for a cluster randomized controlled trial of a behavioral intervention, and also tested blood HIV and herpes simplex type 2 virus at 12- and 24-month follow up; 1,367 male and 1,415 female volunteers were recruited from 70 rural villages. Read More

Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.

Related Articles

Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.

Sex Transm Dis. 2010 Jul;37(7):460-6

Authors: Mavedzenge SN, Pol BV, Cheng H, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, Straten A

BACKGROUND: Trichomonas vaginalis (T. vaginalis) is the most common nonviral sexually transmitted infection in the world. Despite the coexisting global epidemics of T. vaginalis and HIV, little attention has focused on the emerging evidence that T. vaginalis increases susceptibility to, and potentially transmission of, HIV. Read More

Retrospective study on the critical factors for retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa.

Retrospective study on the critical factors for retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa.

J Acquir Immune Defic Syndr. 2010 Sep 1;55(1):109-16

Authors: Vella V, Govender T, Dlamini S, Taylor M, Moodley I, David V, Jinabhai C

OBJECTIVE: To analyze the critical factors favoring the retention of patients under antiretroviral therapy (ART) in KwaZulu-Natal (KZN), South Africa. DESIGN AND METHODS: This retrospective study was based on the review of a representative sample of patients who began ART between March 2004 and May 2006 in 32 public sector sites and were followed up to July 1, 2007.

Extended Cox proportional hazard models were used to identify the factors which significantly influenced treatment retention during the first 2 years of treatment. Kaplan-Meyer provided the probabilities of remaining on ART if these factors were present.

RESULTS: The 2835 sampled patients corresponded to about 10% of the universe of patients under ART in the 32 sites; 929 (33%) were males, and the median age of the sampled patients was 34 (interquartile range: 28-41). The analysis identified factors that significantly decreased the probability of remaining on ART. Patients’ risk factors were initial CD4 <100 cells per microliter, lack of a telephone contact number, and being male. Sites’ risk factors were the presence of a part time (PT) versus a full time (FT) senior professional nurse, a PT versus FT doctor, and intakes of 200 or more new patients per doctor per year. The probability of remaining on ART declined significantly for each increasing level of workload, but having a FT versus a PT doctor made a significant difference only for level of workload of 200 or more new patients per year.

CONCLUSIONS: The analysis has identified the conditions influencing retention of ART patients in KZN. This has provided a method to estimate absorption capacity of the ART delivery sites, which is of added value for a sustainable expansion of the ART coverage.

PMID: 20595904 [PubMed - indexed for MEDLINE]

Go to Source

Virginia Tech professor discovers new TB pathogen

Main symptoms of different variants and stages...
Image via Wikipedia

Kathleen Alexander, associate professor of wildlife in Virginia Tech’s College of Natural Resources and Environment, has discovered a novel tuberculosis (TB) species in the Mycobacterium tuberculosiscomplex, a group of pathogens that have adapted by using mammals as hosts. It has been nearly two decades since a new organism was identified in this group; the majority were discovered in the early and mid 20th century. Read More

Evaluating the BED Capture Enzyme Immunoassay to Estimate HIV Incidence Among Adults in Three Countries in Sub-Saharan Africa.

Evaluating the BED Capture Enzyme Immunoassay to Estimate HIV Incidence Among Adults in Three Countries in Sub-Saharan Africa.

AIDS Res Hum Retroviruses. 2010 Sep 19;

Authors: Kim AA, McDougal JS, Hargrove J, Rehle T, Pillay-Van Wyk V, Puren A, Ekra A, Borget-Alloue MY, Adje-Toure C, Abdullahi AS, Odawo L, Marum L, Parekh BS

Abstract Serological assays for estimating HIV-1 incidence are prone to misclassification, limiting the accuracy of the incidence estimate. Adjustment factors have been developed and recommended for estimating assay-based HIV-1 incidence in cross-sectional settings. We evaluated the performance of the recommended adjustment factors for estimating incidence in national HIV surveys in three countries in sub-Saharan Africa. Read More

Aeras and Crucell announce Phase II clinical trial start in Kenya

Study to test new tuberculosis vaccine in infants

Leiden, The Netherlands / Rockville, MD, USA (September 22, 2010) – Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35. Read More

The emergence of community health worker programmes in the late apartheid era in South Africa: An historical analysis.

The emergence of community health worker programmes in the late apartheid era in South Africa: An historical analysis.

Soc Sci Med. 2010 Sep;71(6):1110-8

Authors: van Ginneken N, Lewin S, Berridge V

There is re-emerging interest in community health workers (CHWs) as part of wider policies regarding task-shifting within human resources for health. This paper examines the history of CHW programmes established in South Africa in the later apartheid years (1970s-1994) – a time of innovative initiatives. After 1994, the new democratic government embraced primary healthcare (PHC), however CHW initiatives were not included in their health plan and most of these programmes subsequently collapsed. Read More

Modeling contextual determinants of HIV/AIDS prevalence in South Africa to inform policy.

Modeling contextual determinants of HIV/AIDS prevalence in South Africa to inform policy.

Afr J Reprod Health. 2009 Sep;13(3):53-69

Authors: Bouare O

There is a voluminous literature on HIV/AIDS and South Africa. However, no study focuses on the modeling of contextual factors concerning HIV/AIDS prevalence in South Africa. In this paper, two models of contextual behavioral risk factors of HIV/AIDS prevalence were developed so that policy makers can be alerted to the key variables in order to help curb the spread of the disease. Read More

SOUTH AFRICA: Nevirapine linked to HIV treatment failure

(PLUSNEWS) – One of the cheapest and most commonly used drugs for treating HIV in Africa – nevirapine – has been associated with an increased risk of treatment failure in a retrospective South African study.
Go to Source

Enhanced by Zemanta

[Newsdesk] Trial results finally show potential for microbicidal HIV gel

Salim and Quarraisha Abdool Karim, husband and wife, and co-principle researchers on the Centre for AIDS Programme of Research in South Africa (CAPRISA) trial, received a standing ovation at the recent International AIDS Society Conference in Vienna when they announced their results, which showed—for the first time—that the use of an antiretroviral microbicidal gel can protect against HIV transmission. Mathematical modelling suggests that, in South Africa alone, this gel can prevent up to 1·3 million new infections and 8000 HIV-related deaths during the next 20 years.
Go to Source

Enhanced by Zemanta

Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.

Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.

AIDS. 2010 Jul 17;24(11):1709-16

Authors: Hoffmann CJ, Fielding KL, Charalambous S, Innes C, Chaisson RE, Grant AD, Churchyard GJ

OBJECTIVE: To assess the effectiveness of cotrimoxazole preventive therapy (CPT) among individuals with CD4 cell count above 200 cells/microl and varying WHO clinical stages in reducing mortality during combination antiretroviral therapy (cART). Read More

South African mutations of the CCR5 coreceptor for HIV modify interaction with chemokines and HIV Envelope protein.

South African mutations of the CCR5 coreceptor for HIV modify interaction with chemokines and HIV Envelope protein.

J Acquir Immune Defic Syndr. 2010 Aug 1;54(4):352-9

Authors: Folefoc AT, Fromme BJ, Katz AA, Flanagan CA

The CCR5 chemokine receptor is the major coreceptor for HIV-1 and the receptor for CC-chemokines, MIP-1alpha, MIP-1beta, and regulated upon activation normal T-cell-expressed and secreted. Individuals, who are homozygous for the nonfunctional CCR5Delta32 allele, are largely resistant to HIV-1 infection. Four unique mutations that affect the amino acid sequence of CCR5 have been identified in South Africa. We have assessed the effect of these mutations on CCR5 interactions with chemokines and HIV Envelope protein. The LeuPhe mutation did not affect CCR5 expression, chemokine binding, intracellular signaling, or interaction with Envelope. The ArgGln mutant was similar to wild-type CCR5, but ligand-independent intracellular signaling suggests that it is partially constitutively active. Read More

Copyright 2002-2012 MednewsAfrica. Creative Commons